Literature DB >> 1714075

Sinus histiocytosis with massive lymphadenopathy: a spectrum of disease associated with immune dysfunction.

D L Maennle1, H L Grierson, D G Gnarra, D D Weisenburger.   

Abstract

A detailed immunologic study of three cases of sinus histiocytosis with massive lymphadenopathy (SHML) was performed to better characterize this rare disorder. One patient had prominent cervical lymphadenopathy that regressed spontaneously, whereas the other two patients had persistent cervical lymphadenopathy and recurrent infections. The first patient was otherwise healthy and had normal immunologic studies. One of the latter patients had a relative increase in blood B cells, a decreased level of serum immunoglobulin A (IgA), decreased blood lymphocyte mitogenic responses to multiple mitogens (37-42% of controls), and cutaneous anergy. The other patient with persistent disease also had a relative increase in blood B cells, polyclonal hypergammaglobulinemia, and circulating immune complexes, as well as decreased blood T cells and markedly decreased blood lymphocyte responses to mitogens (12-37% of controls). Immunohistochemical stains of the lymph nodes of the three patients revealed a characteristic phenotype for the sinus histiocytes: S-100 protein, 3/3; CD14 (Leu M3) 3/3; CD11c (Leu M5), 1/1; CD71 (OKT9), 3/3; CD4 (Leu 3a), 2/3; CD1a (OKT6), 1/3; alpha-1-antitrypsin, 3/3; alpha-1-antichymotrypsin, 3/3; CD35 (C3b), 1/1; CD11b (Mo1), 0/3; CD15 (Leu M1), 0/3; HLA-DR, 0/3; and lysozyme, 0/3. This phenotype suggests that the cells of SHML have features of both the Langerhans/interdigitating cell and mononuclear phagocyte lineages. Emperipolesis by the histiocytes of B cells, T cells, and natural killer cells was demonstrated by a double-staining technique. Our findings indicate that patients with SHML may have a variably expressed immunodeficiency that predisposes them to recurrent infections.

Entities:  

Mesh:

Year:  1991        PMID: 1714075     DOI: 10.3109/15513819109064776

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  6 in total

1.  Sinus histiocytosis with massive lymphadenopathy and giant cell hepatitis. An unreported association.

Authors:  Dimas Suarez-Vilela; Francisco Miguel Izquierdo-Garcia; José Luis Olcoz-Goñi
Journal:  Virchows Arch       Date:  2003-11-18       Impact factor: 4.064

2.  Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case.

Authors:  M Paulli; F Locatelli; S Kindl; E Boveri; F Facchetti; F Porta; R Rosso; L Nespoli; U Magrini
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 3.  Immunity, infection, and nasal disease.

Authors:  S H Yoshida; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  1998 Spring-Summer       Impact factor: 8.667

4.  A rare case of "rosai-dorfman disease".

Authors:  K P Basavaraju; D Chandrika; A M Mallikarjunappa; K B Chandrappa; Rahul Wadhwa
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-06-27

5.  Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.

Authors:  M Paulli; A C Feller; E Boveri; S Kindl; E Berti; R Rosso; H Merz; F Facchetti; C Gambini; F Bonetti
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

6.  Rosai-Dorfman disease with factor XII deficiency.

Authors:  Esen Kasapoglu Gunal; Sevil Kamali; Mehmet Fatih Akdogan; Arif Oguz Cimen; Lale Ocal; Mehmet Agan; Ahmet Gul; Murat Inanc; Meral Konice; Orhan Aral
Journal:  Clin Rheumatol       Date:  2009-03-27       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.